课题基金 / 基金详情

项目摘要

项目成果

ADAM b GLICK的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):国际皮肤癌会议ISCC是一年两次的会议,聚集了来自欧洲、日本和美国的皮肤癌专家以及该领域的博士后研究员和研究生,分享皮肤癌发生机制和预防和治疗策略的研究进展。对皮肤癌发生机制的研究导致了许多与人类所有上皮性癌症相关的标志性发现。这个一年两次的会议的目标是提供一个科学驱动的研讨会,包括说教会议,并促进关于癌症起因和预防的分子和细胞目标的讨论,并提供一个论坛,交流关于肿瘤发展过程中发生的生物、细胞和分子变化的最新和相关信息。通过互动式会议形式继续分享想法和信息,继续促进新的想法和概念的产生,从而改进癌症干预和预防战略。第九届ISCC将包括关于皮肤和miRNA中的癌症干细胞和皮肤癌的前沿会议,以及关于较新的分子靶向药物的皮肤病理学的会议。会议定于2010年6月24日至27日在宾夕法尼亚州立大学的宾夕法尼亚州立学院举行。
英文摘要
DESCRIPTION (provided by applicant): The International Skin Carcinogenesis Conference ISCC is a biannual conference that brings together skin cancer experts from Europe, Japan and the United States as well as postdoctoral fellows and graduate students in this field to share research progress on the mechanisms of skin cancer development and strategies for prevention and therapy. Investigations into the mechanisms of skin cancer development have led to many hallmark discoveries relevant to all epithelial cancers in humans. The goal of this biannual conference is to provide a scientifically driven symposium involving didactic sessions and facilitating discussions regarding molecular and cellular targets of cancer causation and prevention and to provide a forum for exchange of the most recent and relevant information on the biological, cellular and molecular changes that occur during tumor development. A continued sharing of ideas and information through an interactive conference format continues to foster the creation of new ideas and concepts thus leading to improved strategies for cancer intervention and prevention. For the Ninth International ISCC will include cutting edge sessions on cancer stem cells in the skin and miRNA and skin cancer as well as sessions on skin pathologies of newer molecularly targeted drugs. The conference is scheduled for June 24-27, 2010 in State College Pennsylvania at the Penn State University.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IRE1a: a Conditional Tumor Suppressor
IRE1a: a Conditional Tumor Suppressor
IRE1a: a Conditional Tumor Suppressor
IRE1a: a Conditional Tumor Suppressor
海外基金